GlassScriptPhysician profile
Michael M Leighton
NPI 1669433447
$5,943.84
in general payments reported to CMS, 2019-2025
19 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $126 · 2021: $404 · 2022: $769 · 2023: $356 · 2024: $1,811 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.27 |
| Travel and Lodging | $840.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,873.84 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Insignia |
| Smith+Nephew, INC. | $816.85 | 2019-2025 | Healicoil, Q-Fix, Real Intelligence |
| Depuy Synthes Sales INC. | $178.33 | 2019-2023 | Orthovisc, Monovisc |
| Orthofix Medical, INC. | $169.57 | 2024-2025 | Spinal-Stim, Physio-Stim |
| Medacta USA, INC. | $168.20 | 2021-2022 | |
| Djo, LLC | $138.94 | 2023-2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $125.68 | 2022-2024 | Tapestry |
| Conformis, INC. | $105.96 | 2022 | |
| Vericel Corporation | $95.05 | 2022-2025 | Maci |
| Ethicon US, LLC | $51.69 | 2021-2022 | |
| Bioventus LLC | $45.19 | 2025 | Xcell |
| Southern Edge Orthopaedics, INC. | $35.83 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.30 | 2022-2023 | Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $25.70 | 2022 | |
| Heron Therapeutics, INC. | $20.62 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $17.93 | 2024 | Trivisc Sodium Hyaluronate |
| Fidia Pharma USA INC. | $15.45 | 2025 | Hymovis |
| Assertio Therapeutics, INC. | $14.84 | 2019 | |
| Dynasplint Systems INC. | $12.87 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Leighton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.